Physical Impairments in Premature Ventricular Complex

Официальное название

Investigation of Respiratory Functions, Muscle Strength, Physical Activity Level, and Quality of Life in Individuals With Premature Ventricular Complexes

Обзор

Premature ventricular complexes may be observed in individuals without underlying disease due to factors such as physical inactivity, advanced age, smoking, male sex, and psychosocial disturbances, and in some cases may result in sudden cardiac death. Therefore, the aim of this study is to investigate respiratory function, respiratory muscle strength, cough strength, handgrip strength, physical activity level, and quality of life in individuals with premature ventricular complexes.

Подробное описание

The primary aim of this study is to comprehensively investigate respiratory function, respiratory muscle strength, cough strength, handgrip strength, physical activity level, and quality of life in individuals with premature ventricular complexes. Additionally, an important secondary aim is to identify potential differences in these parameters between individuals with premature ventricular complexes and healthy controls and to contribute original findings to the existing literature.Participants will be evaluated in terms of these parameters through clinical assessments, questionnaires, and measurements.

Вмешательства

• Другое Physical Evaluations of Patients with Premature Ventricular Complex
  In this study, data from individuals with premature ventricular complex will be collected through face-to-face assessments. Respiratory functions, respiratory and peripheral muscle strength, cough strength, physical activity level, and quality of life will be assessed in these individuals who meet the inclusion criteria. All data obtained through these assessments will be collected from participants face-to-face at one time and for a maximum of approximately 1 hour.
• Другое Physical Evaluations of Healthy Individuals
  In this study, data from healthy individuals will be collected through face-to-face assessments. Respiratory functions, respiratory and peripheral muscle strength, cough strength, physical activity level, and quality of life will be assessed in these individuals who meet the inclusion criteria.All data obtained through these assessments will be collected from participants face-to-face at one time and for a maximum of approximately 1 hour.

Первичные конечные точки

• Maximal inspiratory pressure (MIP) [Срок оценки: through study completion, an average of 1 year]

Вторичные конечные точки (9)

• Maximal expiratory pressure (MEP) [Срок оценки: through study completion, an average of 1 year]
• Forced vital capacity (FVC) [Срок оценки: through study completion, an average of 1 year]
• Forced expiratory volume in the first second (FEV1) [Срок оценки: through study completion, an average of 1 year]
• FEV1 / FVC [Срок оценки: through study completion, an average of 1 year]
• Peak flow rate (PEF) [Срок оценки: through study completion, an average of 1 year]
• Cough Strength [Срок оценки: through study completion, an average of 1 year]
• Handgrip Strength [Срок оценки: through study completion, an average of 1 year]
• Assessment of Physical Activity [Срок оценки: through study completion, an average of 1 year]
• Assessment of Quality of Life [Срок оценки: through study completion, an average of 1 year]

Критерии участия

Inclusion Criteria for Individuals with Premature Ventricular Complexes (PVCs):

• Aged between 18 and 80 years
• Presence of symptomatic premature ventricular complexes resistant to ≥1 antiarrhythmic medication (including β-blockers and calcium channel blockers)
• Premature ventricular complex burden ≥10%
• Ventricular arrhythmias originating from any focus within the right or left ventricle
• Physically able to participate in all study assessments
• Willingness to participate in the study by providing written informed consent

Inclusion Criteria for Control Group Participants:

• Aged between 18 and 80 years
• Healthy individuals
• Willingness to participate in the study
• Physically able to participate in all study assessments

Exclusion Criteria for Individuals with Premature Ventricular Complexes (PVCs):

• Left ventricular ejection fraction (LVEF) <45% unless PVC-induced cardiomyopathy is documented (defined as a >15% improvement in LVEF following reduction of PVC burden through pharmacological therapy or ablation)
• Progressive decline in LVEF within the last 4 months, regardless of etiology
• Severe heart failure classified as New York Heart Association (NYHA) Class ≥III
• Ventricular arrhythmias attributed to underlying structural heart disease, known myocardial scar, or myocarditis
• Change in the dosage of antiarrhythmic medications (including β-blockers and calcium channel blockers) within 2 months prior to enrollment
• Failed catheter ablation within 3 months prior to enrollment
• Known thyroid disorders or individuals undergoing renal dialysis
• Life expectancy <12 months
• Presence of angina pectoris
• Diagnosis of chronic obstructive pulmonary disease (COPD) or asthma
• Resting heart rate >120 beats/min
• Resting systolic blood pressure ≥180 mmHg
• Resting diastolic blood pressure ≥100 mmHg
• Resting peripheral oxygen saturation ≤90%

Exclusion Criteria for Control Group Participants:

• Presence of premature ventricular complexes
• Presence of any acute or chronic medical condition

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Модель наблюдения

Случай-контроль

Центры проведения

Turkey (Türkiye) · 1 центр

• Izmir Democracy University — Izmir

Публикации

• Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M; ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhyth PMID 36017572
• Aktan R, Ocaker Aktan O, Ozalevli S, Dursun H. Impact of Inspiratory Muscle Strength and Lung Function on Functional Exercise Capacity in Post-myocardial Infarction Patients: A Cross-sectional Study. Thorac Res Pract. 2025 Oct 24;26(6):307-313. doi: 10.4274/ThoracResPract.2025.2025-7-5. Epub 2025 Sep 18. PMID 40960384

Идентификаторы

NCT: NCT07396597 · Premature Ventricular Complex

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗